drugset / Trial / NCT00867360

Treatment of Psychotic Major Depression With Mifepristone

NCT00867360

Phase 3 Terminated 10 enrolled Stanford University
RandomizedSingle-groupTriple-blindTreatment

Summary

The purpose of this research study is to see how certain hormones cause changes in mood and thinking in some depressed patients and to determine the effectiveness of mifepristone in treating some forms of depression. This study is conducted in conjunction with an observational study "Clinical and Biological Characteristics of Psychotic Depression".

Timeline

Start
2005-08
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Mifepristone Small molecule 600 mg Oral
Subject Mifepristone Small molecule 1200 mg Oral